Events - Event View

Presented By: Chris Flynn, MD

Program Learning Objectives – At the conclusion of this activity participants will be able to:

• Recognize that some established and some recently introduced psychiatry therapeutics may not be used by pilots who wish to continue to fly - combination medications therapy, medication assisted substance abuse treatment, ketamine, transcranial magnetic stimulation, psilocybin, vagal nerve stimulation, and stellate ganglion nerve block;
• Utilize your empathy with an airman’s occupational fears of losing their career to decrease the airman’s resistance and increase your diagnostic accuracy; and
• Apply the knowledge that a wide range of Mental Health conditions in pilots are approved (once in stable remission) for a return to flying by the Federal Aviation Administration.

Accreditation and Designation Statement

In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and Washington Psychiatric Society. The American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The American Psychiatric Association (APA) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.